The global measles vaccine market is expected to grow at a CAGR of 4.5% from 2021 to 2030. The growth of the market can be attributed to the increasing number of cases of measles and mumps in various regions across the globe, which is driving demand for vaccines. In addition, technological advancements in vaccine manufacturing are also contributing to the growth of this market.
Mumps Measles Rubella Vaccine segment accounted for over 50% share in 2018 and is expected to maintain its dominance throughout the forecast period owing to its high efficacy against these diseases. Live (MMII) segment accounted for over 30% share in 2018 and is expected to grow at a CAGR of 5.2%. Mumps Measles Rubella and Varicella Virus Vaccine (Proquad) segment accounted for over 10% share in 2018 and is expected to grow at a CAGR of 3%.
- The measles vaccine is a safe and effective way to prevent the disease.
- The measles vaccine is recommended for all children, adolescents, and adults who do not have evidence of immunity against measles.
- Measles vaccination has been shown to reduce the risk of death from measles by more than 95%.
- Measles vaccination has been shown to reduce the risk of hospitalization from measles by more than 90%.
- Measles vaccination has been shown to reduce the risk of complications such as pneumonia, encephalitis (swelling in brain), and blindness by more than 50%.
Industry Growth Insights published a new data on “Measles Vaccine Market”. The research report is titled “Measles Vaccine Market research by Types (Mumps Measles Rubella Vaccine, Live (MMR-II), Mumps Measles Rubella and Varicella Virus Vaccine (Proquad)), By Applications (Children, Adults), By Players/Companies GSK, Sanofi-Pasteur, Merck, Novartis, Pfizer, Serum Institute of India, China National Biotech Group, Bavarian Nordic, Emergent Biosolutions, Medimmune, Johnson & Johnson, CSL Limited”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Measles Vaccine Market Research Report
By Type
Mumps Measles Rubella Vaccine, Live (MMR-II), Mumps Measles Rubella and Varicella Virus Vaccine (Proquad)
By Application
Children, Adults
By Companies
GSK, Sanofi-Pasteur, Merck, Novartis, Pfizer, Serum Institute of India, China National Biotech Group, Bavarian Nordic, Emergent Biosolutions, Medimmune, Johnson & Johnson, CSL Limited
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
236
Number of Tables & Figures
166
Customization Available
Yes, the report can be customized as per your need.
Global Measles Vaccine Market Report Segments:
The global Measles Vaccine market is segmented on the basis of:
Types
Mumps Measles Rubella Vaccine, Live (MMR-II), Mumps Measles Rubella and Varicella Virus Vaccine (Proquad)
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Children, Adults
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- GSK
- Sanofi-Pasteur
- Merck
- Novartis
- Pfizer
- Serum Institute of India
- China National Biotech Group
- Bavarian Nordic
- Emergent Biosolutions
- Medimmune
- Johnson & Johnson
- CSL Limited
Highlights of The Measles Vaccine Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Mumps Measles Rubella Vaccine, Live (MMR-II)
- Mumps Measles Rubella and Varicella Virus Vaccine (Proquad)
- By Application:
- Children
- Adults
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Measles Vaccine Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Measles vaccine is a vaccine that helps protect people from measles. It is made from a dead virus and helps the body build immunity to the disease. Measles vaccine can help prevent measles if it is given before someone becomes infected with the virus.
Some of the major players in the measles vaccine market are GSK, Sanofi-Pasteur, Merck, Novartis, Pfizer, Serum Institute of India, China National Biotech Group, Bavarian Nordic, Emergent Biosolutions, Medimmune, Johnson & Johnson, CSL Limited.
The measles vaccine market is expected to register a CAGR of 4.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Measles Vaccine Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Measles Vaccine Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Measles Vaccine Market - Supply Chain
4.5. Global Measles Vaccine Market Forecast
4.5.1. Measles Vaccine Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Measles Vaccine Market Size (000 Units) and Y-o-Y Growth
4.5.3. Measles Vaccine Market Absolute $ Opportunity
5. Global Measles Vaccine Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Measles Vaccine Market Size and Volume Forecast by Type
5.3.1. Mumps Measles Rubella Vaccine, Live (MMR-II)
5.3.2. Mumps Measles Rubella and Varicella Virus Vaccine (Proquad)
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Measles Vaccine Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Measles Vaccine Market Size and Volume Forecast by Application
6.3.1. Children
6.3.2. Adults
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Measles Vaccine Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Measles Vaccine Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Measles Vaccine Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Measles Vaccine Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Measles Vaccine Demand Share Forecast, 2019-2029
9. North America Measles Vaccine Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Measles Vaccine Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Measles Vaccine Market Size and Volume Forecast by Application
9.4.1. Children
9.4.2. Adults
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Measles Vaccine Market Size and Volume Forecast by Type
9.7.1. Mumps Measles Rubella Vaccine, Live (MMR-II)
9.7.2. Mumps Measles Rubella and Varicella Virus Vaccine (Proquad)
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Measles Vaccine Demand Share Forecast, 2019-2029
10. Latin America Measles Vaccine Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Measles Vaccine Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Measles Vaccine Market Size and Volume Forecast by Application
10.4.1. Children
10.4.2. Adults
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Measles Vaccine Market Size and Volume Forecast by Type
10.7.1. Mumps Measles Rubella Vaccine, Live (MMR-II)
10.7.2. Mumps Measles Rubella and Varicella Virus Vaccine (Proquad)
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Measles Vaccine Demand Share Forecast, 2019-2029
11. Europe Measles Vaccine Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Measles Vaccine Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Measles Vaccine Market Size and Volume Forecast by Application
11.4.1. Children
11.4.2. Adults
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Measles Vaccine Market Size and Volume Forecast by Type
11.7.1. Mumps Measles Rubella Vaccine, Live (MMR-II)
11.7.2. Mumps Measles Rubella and Varicella Virus Vaccine (Proquad)
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attrctiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Measles Vaccine Demand Share, 2019-2029
12. Asia Pacific Measles Vaccine Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Measles Vaccine Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Measles Vaccine Market Size and Volume Forecast by Application
12.4.1. Children
12.4.2. Adults
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Measles Vaccine Market Size and Volume Forecast by Type
12.7.1. Mumps Measles Rubella Vaccine, Live (MMR-II)
12.7.2. Mumps Measles Rubella and Varicella Virus Vaccine (Proquad)
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Measles Vaccine Demand Share, 2019-2029
13. Middle East & Africa Measles Vaccine Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Measles Vaccine Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Measles Vaccine Market Size and Volume Forecast by Application
13.4.1. Children
13.4.2. Adults
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Measles Vaccine Market Size and Volume Forecast by Type
13.7.1. Mumps Measles Rubella Vaccine, Live (MMR-II)
13.7.2. Mumps Measles Rubella and Varicella Virus Vaccine (Proquad)
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Measles Vaccine Demand Share, 2019-2029
14. Competition Landscape
14.1. Global Measles Vaccine Market: Market Share Analysis
14.2. Measles Vaccine Distributors and Customers
14.3. Measles Vaccine Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. GSK
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Sanofi-Pasteur
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Merck
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Novartis
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Pfizer
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Serum Institute of India
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. China National Biotech Group
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Bavarian Nordic
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Emergent Biosolutions
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Medimmune
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Johnson & Johnson
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. CSL Limited
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
